These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 11000561)
1. The role of nuclear medicine in inflammatory bowel disease. A review with experiences of aspecific bowel activity using immunoscintigraphy with 99mTc anti-granulocyte antibodies. Györke T; Duffek L; Bártfai K; Makó E; Karlinger K; Mester A; Tarján Z Eur J Radiol; 2000 Sep; 35(3):183-92. PubMed ID: 11000561 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of endoscopy, radiology and scintigraphy with Tc-99m-exametazine labeled leukocytes and In-111 labeled human polyclonal immunoglobulin G in the diagnosis of inflammatory bowel disease]. de Lima Ramos PA; Martín-Comin J; Muñoz A; Baliellas C; Vilar L; Roca M; Ramos M Med Clin (Barc); 1998 Sep; 111(7):241-6. PubMed ID: 9789237 [TBL] [Abstract][Full Text] [Related]
3. Clinical applications of radiolabeled blood elements in inflammatory bowel disease. Martin-Comin J; Prats E Q J Nucl Med; 1999 Mar; 43(1):74-82. PubMed ID: 10230283 [TBL] [Abstract][Full Text] [Related]
4. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease. Giaffer MH; Tindale WB; Holdsworth D Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940 [TBL] [Abstract][Full Text] [Related]
5. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection. Gratz S; Behr T; Herrmann A; Dresing K; Tarditi L; Franceschini R; Rhodes B; Stürmer KM; Becker W Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168 [TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods. Mansfield JC; Giaffer MH; Tindale WB; Holdsworth CD Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945 [TBL] [Abstract][Full Text] [Related]
7. Comparison between Tc-HMPAO labelled white cells and Tc LeukoScan in the investigation of inflammatory bowel disease. Kerry JE; Marshall C; Griffiths PA; James MW; Scott BB Nucl Med Commun; 2005 Mar; 26(3):245-51. PubMed ID: 15722905 [TBL] [Abstract][Full Text] [Related]
8. Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphy. Stathaki MI; Koutroubakis IE; Koukouraki SI; Karmiris KP; Moschandreas JA; Kouroumalis EA; Karkavitsas NS Nucl Med Commun; 2008 Jan; 29(1):27-32. PubMed ID: 18049094 [TBL] [Abstract][Full Text] [Related]
9. Clinical applications of technetium Tc 99m hexamethyl propylene amine oxime leukocyte scan in children with inflammatory bowel disease. Del Rosario MA; Fitzgerald JF; Siddiqui AR; Chong SK; Croffie JM; Gupta SK J Pediatr Gastroenterol Nutr; 1999 Jan; 28(1):63-70. PubMed ID: 9890471 [TBL] [Abstract][Full Text] [Related]
10. Scintigraphy with 99mTc-HMPAO labeled leukocytes is still an accurate and convenient tool to rule out suspected inflammatory bowel disease in children. Chroustová D; El-Lababidi N; Trnka J; Černa L; Lambert L Nucl Med Rev Cent East Eur; 2019; 22(2):69-73. PubMed ID: 31482559 [TBL] [Abstract][Full Text] [Related]
11. Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease. Papos M; Nagy F; Narai G; Rajtar M; Szantai G; Lang J; Csernay L Dig Dis Sci; 1996 Feb; 41(2):412-20. PubMed ID: 8601391 [TBL] [Abstract][Full Text] [Related]
13. Antigranulocyte monoclonal antibody immunoscintigraphy in inflammatory bowel disease in children and young adolescents. Bruno I; Martelossi S; Geatti O; Maggiore G; Guastalla P; Povolato M; Ventura A Acta Paediatr; 2002; 91(10):1050-5. PubMed ID: 12434889 [TBL] [Abstract][Full Text] [Related]
14. Labelled leukocytes for diagnosis of infectious diseases. Our experience in labelling and clinical usefulness. Tagliabue L; Majoli C; Pajoro U; Musarra M; Di Leo C; Del Sole A; Bestetti A; Tarolo GL Minerva Med; 2000; 91(11-12):267-74. PubMed ID: 11253707 [TBL] [Abstract][Full Text] [Related]
15. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease. Alonso JC; Lopez-Longo FJ; Lampreave JL; González CM; Vegazo O; Carreño L; Almoguera I Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954 [TBL] [Abstract][Full Text] [Related]
16. Scintigraphic head-to-head comparison between 99mTc-WBCs and 99mTc-LeukoScan in the evaluation of inflammatory bowel disease: a pilot study. Stokkel MP; Reigman HE; Pauwels EK Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):251-4. PubMed ID: 11930885 [TBL] [Abstract][Full Text] [Related]
17. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease. Allan RA; Sladen GE; Bassingham S; Lazarus C; Clarke SE; Fogelman I Eur J Nucl Med; 1993 Mar; 20(3):195-200. PubMed ID: 8462606 [TBL] [Abstract][Full Text] [Related]
18. Is it possible to assess disease activity of inflammatory bowel disease with scintigraphy? Arndt JW; Grootscholten MI Neth J Med; 1996 Feb; 48(2):49-52. PubMed ID: 8819798 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease: value in diagnosis and management of MDCT-enteroclysis and 99mTc-HMPAO labeled leukocyte scintigraphy. Grassi R; Rambaldi PF; Di Grezia G; Mansi L; Cuccurullo V; Cirillo A; Riegler G; Cappabianca S; Rotondo A Abdom Imaging; 2011 Aug; 36(4):372-81. PubMed ID: 20963584 [TBL] [Abstract][Full Text] [Related]